NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
A federal judge overseeing Stryker Rejuvenate hip implant liability claims has set the stage with the pretrial order. The Stryker Corporation, manufacturers of the Rejuvenate implant, is involved in five new lawsuits in New Jersey, with an additional 2000 + lawsuits pending in other federal courts including in Minnesota and Florida. The hip replacement corporation estimates the cost of resolution through litigation concerning lawsuits on the Rejuvenate device could cost more than $1.1 billion.
All cases have been consolidated as a part of the pretrial proceedings under Multi-District litigation (MDL), overseen by Judge Frank (see here for discussion of the MDL process and certification). The court issued a joint report and agenda indicating the status of more than 1040 open Minnesota cases under the MDL, with another 1180 pending cases in New Jersey courts and more than 60 Florida cases and 23 additional cases spread across Oregon, Michigan, Indiana and California.